Ronald M Kurtz MD insider trades

Open-market stock purchases and sales by Ronald M Kurtz MD, President & CEO at RxSight, Inc, from SEC Form 4 filings since Jul 31, 2021.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -65%.

Recent trades

DateStockTradeValue
Feb 27, 2026RXST RxSight, IncBought (not open market)—

Companies traded

  • RXST RxSight, Inc: 2 buys, 4 sales, last Feb 27, 2026

Get free alerts when Ronald M Kurtz MD files a new trade →